BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2233825)

  • 1. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/3. Animal studies suggesting involvement of mutagen/carcinogen exposure in atherosclerosis.
    Wakabayashi K
    Mutat Res; 1990 Nov; 239(3):181-7. PubMed ID: 2233825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. The possible involvement of somatic mutations in the development of atherosclerotic plaques. Report of ICPEMC Subcommittee 7/1. Conclusions and recommendations.
    Mutat Res; 1990 Nov; 239(3):143-8. PubMed ID: 2233823
    [No Abstract]   [Full Text] [Related]  

  • 3. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis--a review of the epidemiological evidence.
    Hansen ES
    Mutat Res; 1990 Nov; 239(3):163-79. PubMed ID: 2233824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of chemical carcinogens to induce atherosclerosis in the white Carneau pigeon.
    Revis NW; Bull R; Laurie D; Schiller CA
    Toxicology; 1984 Sep; 32(3):215-27. PubMed ID: 6089378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental carcinogens and mutational pathways in atherosclerosis.
    Pulliero A; Godschalk R; Andreassi MG; Curfs D; Van Schooten FJ; Izzotti A
    Int J Hyg Environ Health; 2015 May; 218(3):293-312. PubMed ID: 25704189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC working paper 2/3: carcinogens and carcinogenesis enhancers.
    Clayson DB
    Mutat Res; 1981 Mar; 86(2):217-29. PubMed ID: 7266570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.
    Atherosclerosis; 1991 Aug; 89(2-3):255-61. PubMed ID: 1793453
    [No Abstract]   [Full Text] [Related]  

  • 8. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons.
    Penn A; Snyder C
    Carcinogenesis; 1988 Dec; 9(12):2185-9. PubMed ID: 3142695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carcinogens on chicken atherosclerosis.
    Albert RE; Vanderlaan M; Burns FJ; Nishizumi M
    Cancer Res; 1977 Jul; 37(7 Pt 1):2232-5. PubMed ID: 405095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.
    Jansen JD
    Regul Toxicol Pharmacol; 1984 Jun; 4(2):138-44. PubMed ID: 6739865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airborne mutagens and carcinogens from cooking and other food preparation processes.
    Löfroth G
    Toxicol Lett; 1994 Jun; 72(1-3):83-6. PubMed ID: 8202960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/1. Mutational events in the etiology of arteriosclerotic plaques.
    Penn A
    Mutat Res; 1990 Nov; 239(3):149-62. PubMed ID: 2122242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Commission for Protection against Environmental Mutagens and Carcinogens ICPEMC working paper 2/8: An evaluation of assay procedures for detection of tumor promotors.
    Sivak A
    Mutat Res; 1982 May; 98(3):377-87. PubMed ID: 7050698
    [No Abstract]   [Full Text] [Related]  

  • 14. The food-derived heterocyclic amines and breast cancer: a 1995 perspective.
    Synderwine EG
    Recent Results Cancer Res; 1996; 140():17-25. PubMed ID: 8787060
    [No Abstract]   [Full Text] [Related]  

  • 15. Mammalian cell transformation and cell-mediated mutagenesis by carcinogenic polycyclic hydrocarbons.
    Huberman E
    Mutat Res; 1975 Aug; 29(2):285-91. PubMed ID: 1186764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Topic No. 1. Are somatic mutations involved in atherosclerosis?
    Bridges BA
    Mutat Res; 1987 Dec; 182(6):301-2. PubMed ID: 3683430
    [No Abstract]   [Full Text] [Related]  

  • 17. Further investigations of the capacity of polynuclear aromatic hydrocarbons to elicit atherosclerotic lesions.
    Bond JA; Gown AM; Yang HL; Benditt EP; Juchau MR
    J Toxicol Environ Health; 1981 Feb; 7(2):327-35. PubMed ID: 6262518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogenicity of food mutagens.
    Sugimura T; Nagao M; Wakabayashi K
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):429-33. PubMed ID: 8781358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals.
    Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H
    Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.